COMPLEMENT FACTOR B (CFB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20250027080A1
SERIAL NO

18598006

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the complement factor B (CFB) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of a CFB gene and to methods of treating or preventing a CFB-associated disease in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC300 THIRD STREET 3RD FLOOR CAMBRIDGE MA 02142-1110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Castoreno, Adam Framingham, US 62 8
Fishilevich, Elane Rochester, US 48 15
McIninch, James D Burlington, US 80 141
Schlegel, Mark K Boston, US 71 33
Yucius, Kristina Burlington, US 5 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation